Ece Sönmezler

Ece Sönmezler

Auto-generated profile, based on publicly available information

Ece Sönmezler

Izmir Biomedicine and Genome Institute, Dokuz Eylul University, Izmir, Türkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in iScience
Verified
Journal Article
Open access
SGSerdal Gungor
Serdal Gungor
YOYavuz Oktay
Yavuz Oktay
SHSemra Hiz
Semra Hiz
ÁAÁlvaro Aranguren-Ibáñez
Álvaro Aranguren-Ibáñez
IKIpek Kalafatcilar
Ipek Kalafatcilar
RHRita Horvath
Rita Horvath
Microtubules help building the cytoskeleton of neurons and other cells. Several components of the gamma-tubulin (γ-tubulin) complex have been previously reported in human neurodevelopmental diseases. We describe two siblings from a consanguineous Turkish family with dysmorphic features, developmental delay, brain malformation, and epilepsy carrying a homozygous mutation (p.Glu311Lys) in TUBGCP2 encoding the γ-tubulin complex 2 (GCP2) protein. This variant is predicted to disrupt the electrostatic interaction of GCP2 with GCP3. In primary fibroblasts carrying the variant, we observed a faint delocalization of γ-tubulin during the cell cycle but normal GCP2 protein levels. Through mass spectrometry, we observed dysregulation of multiple proteins involved in the assembly and organization of the cytoskeleton and the extracellular matrix, controlling cellular adhesion and of proteins crucial for neuronal homeostasis including axon guidance. In summary, our functional and proteomic studies link TUBGCP2 and the γ-tubulin complex to the development of the central nervous system in humans.

28 May 2024 in Human Mutation
Verified
Journal Article
Open access
ESEce Sönmezler
Ece Sönmezler
CSCristiana Stuani
Cristiana Stuani
SKSemra Hız Kurul
Semra Hız Kurul
SGSerdal Güngör
Serdal Güngör
Emanuele BurattiEmanuele Buratti
Emanuele Buratti
YOYavuz Oktay
Yavuz Oktay
Although they are rare in the population, rare neurodevelopmental disorders (RNDDs) constitute a significant portion of all rare diseases. While advancements in sequencing technologies led to improvements in diagnosing and managing rare neurodevelopmental diseases, accurate pathogenicity classification of the identified variants is still challenging. Sequence variants altering pre-mRNA splicing make up a significant part of pathogenic variants. Despite advances in the in silico prediction tools, noncanonical splice site variants are one of the groups of variants that pose a challenge in their clinical interpretation. In this study, we analyzed the effects of seven splicing variants we had previously proposed as disease-causing and demonstrated that all but one of the seven variants had a strong or moderate effect on splicing, as assessed by a minigene assay. Next, applying U1 snRNAs engineered for different splicing variants in the corresponding genes and expressed with minigene plasmids in HeLa cells provided a partial correction in four of the studied genes to varying degrees. Findings from our study highlight the importance of in vitro minigene-based assays for the reclassification of putative splice-altering variants of uncertain significance and the therapeutic potential of modified U1 snRNAs in RNDDs.
1

14 February 2023 in Neuropediatrics
Verified
Journal Article
Closed access
PDF file
ÇGÇağatay Günay
Çağatay Günay
DADuygu Aykol
Duygu Aykol
ÖÖÖzlem Özsoy
Özlem Özsoy
ESEce Sönmezler
Ece Sönmezler
YHYaren Sena Hanci
Yaren Sena Hanci
HGHande Gazeteci
Hande Gazeteci
Background Although the underlying genetic causes of intellectual disability (ID) continue to be rapidly identified, the biological pathways and processes that could be targets for a potential molecular therapy are not yet known. This study aimed to identify ID-related shared pathways and processes utilizing enrichment analyses.Methods In this multicenter study, causative genes of patients with ID were used as input for Disease Ontology (DO), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes enrichment analysis.Results Genetic test results of 720 patients from 27 centers were obtained. Patients with chromosomal deletion/duplication, non-ID genes, novel genes, and results with changes in more than one gene were excluded. A total of 558 patients with 341 different causative genes were included in the study. Pathway-based enrichment analysis of the ID-related genes via ClusterProfiler revealed 18 shared pathways, with lysine degradation and nicotine addiction being the most common. The most common of the 25 overrepresented DO terms was ID. The most frequently overrepresented GO biological process, cellular component, and molecular function terms were regulation of membrane potential, ion channel complex, and voltage-gated ion channel activity/voltage-gated channel activity, respectively.Conclusion Lysine degradation, nicotine addiction, and thyroid hormone signaling pathways are well-suited to be research areas for the discovery of new targeted therapies in ID patients.

11 September 2025 in Rare
Verified
Journal Article
Open access
BUBegum Utz
Begum Utz
ETEmine Eylul Taskin
Emine Eylul Taskin
AYAyca Yigit
Ayca Yigit
EOEmre Ozzeybek
Emre Ozzeybek
KBKutay Bulut
Kutay Bulut
UOUgur Ozbek
Ugur Ozbek

17 October 2026 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
HBHILMI BOLAT
HILMI BOLAT
HAHilal Aydin
Hilal Aydin
DGDilan Genç-Akdağ
Dilan Genç-Akdağ
IKIrem Kalay
Irem Kalay
MÖMurat Öztürk
Murat Öztürk
GÜGül Ünsel-Bolat
Gül Ünsel-Bolat

13 October 2026 in Human Molecular Genetics
Verified
Journal Article
Open access
ESEce Sönmezler
Ece Sönmezler
SKSemra Hız Kurul
Semra Hız Kurul
OEOzlem Erez
Ozlem Erez
BEBurcu Ekinci
Burcu Ekinci
TYTutku Yaraş
Tutku Yaraş
YOYavuz Oktay
Yavuz Oktay
Katanins are microtubule-severing ATPases. Dysfunction of katanin subunits has been implicated in impaired neurogenesis, morphogenesis, and neuronal migration. Although heterozygous variants in KATNAL2 (katanin-like 2), a known autism-spectrum disorder (ASD) risk gene, have been reported in patients with ASD or other neurodevelopmental disorders (NDD), the underlying cellular mechanisms remain incompletely defined. Whole-exome sequencing (WES) identified a homozygous missense variant in KATNAL2 (NM_001387690.1:c.1390T>C; p.(Ser464Pro)) in a pediatric patient presenting with severe global developmental delay, intellectual disability, infantile-onset epilepsy, and autistic features, extending the phenotypic spectrum beyond prior autism-focused associations. To elucidate the cellular mechanisms underlying KATNAL2 dysfunction, we established induced pluripotent stem cells (iPSCs) from patient fibroblasts and differentiated them into neural progenitor cells (NPCs) for quantitative immunofluorescence analyses of microtubule organization, microtubule regulatory proteins, and transcriptome profiling. In parallel, we generated CRISPR/Cas9 katnal2 zebrafish crispants and assessed body patterning and axonal projections using the transgenic nbt:dsRed line. Patient iPSC-derived NPCs showed impaired interphase microtubule network organization with increased angular standard deviation in directionality and mitotic/cytokinetic abnormalities, including abnormal positioning of the microtubule-rich cytokinetic midbody region. In vivo, CRISPR/Cas9 katnal2 zebrafish crispants showed abnormal body patterning together with disorganized motor neuron and posterior lateral line nerve axonal projections. Together, these findings support KATNAL2 as a regulator of microtubule network organization and mitotic progression in human NPCs. Our data from patient-derived NPCs and a zebrafish model provide functional evidence linking the p.(Ser464Pro) variant to an expanded syndromic neurodevelopmental phenotype.